Amedeo Smart

Free Medical Literature Service

 

Amedeo

Thoracic Surgery
  Free Subscription

Articles published in
Am Heart J
    April 2024
  1. ETIWY M, Flannery LD, Li SX, Morrison FJ, et al
    Examining Lack of Referrals to Heart Valve Specialists as Mechanisms of Potential Underutilization of Aortic Valve Replacement.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00093-0. doi: 10.1016/j.ahj.2024.
    >> Share

    March 2024
  2. GUINOT PG, Desebbe O, Besch G, Guerci P, et al
    Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial).
    Am Heart J. 2024 Mar 14:S0002-8703(24)00068-1. doi: 10.1016/j.ahj.2024.
    >> Share

  3. KRUCOFF M, Spirito A, Baber U, Sartori S, et al
    Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
    Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
    >> Share

  4. DOU D, Yuan S, Jia Y, Wang Y, et al
    The protocol of enhanced recovery after cardiac surgery in adult patients: a stepped wedge cluster randomized trial.
    Am Heart J. 2024 Mar 2:S0002-8703(24)00051-6. doi: 10.1016/j.ahj.2024.
    >> Share

  5. KIM M, Ahn JM, Kang DY, Kim MJ, et al
    Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
    Am Heart J. 2024;269:167-178.
    >> Share

    February 2024
  6. ZHANG J, Kong XQ, Gao XF, Chen J, et al
    Transfemoral transcatheter aortic valve replacement with VitaFlow(TM) valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial.
    Am Heart J. 2024 Feb 25:S0002-8703(24)00049-8. doi: 10.1016/j.ahj.2024.
    >> Share

  7. KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al
    TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic Valve Stenosis and M
    Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024.
    >> Share

    January 2024
  8. ASHWAT E, Brown JA, Yousef S, Ahmad D, et al
    Radial Artery versus Right Internal Mammary Artery as a Second Conduit during Coronary Artery Bypass Grafting.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024.
    >> Share

  9. JAMMOUL N, Dupasquier V, Akodad M, Meunier PA, et al
    Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00014-0. doi: 10.1016/j.ahj.2024.
    >> Share

    December 2023
  10. HEGEMAN RRMJJ, van Ginkel DJ, Langle S, Timmers L, et al
    Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve implantation: Design and rationale of the GUIDE-TAVI trial.
    Am Heart J. 2023 Dec 30:S0002-8703(23)00360-5. doi: 10.1016/j.ahj.2023.
    >> Share

  11. GENEREUX P, Schwartz A, Oldemeyer B, Cohen DJ, et al
    Design and Rationale of the Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis: The EARLY TAVR Trial.
    Am Heart J. 2023 Dec 4:S0002-8703(23)00326-5. doi: 10.1016/j.ahj.2023.
    >> Share

  12. DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al
    Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
    Am Heart J. 2023;266:168-175.
    >> Share

    November 2023
  13. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    >> Share

  14. FOOTE HP, Thibault D, Gonzalez CD, Hill GD, et al
    Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry.
    Am Heart J. 2023;265:143-152.
    >> Share

    October 2023
  15. BARON SJ, Ryan MP, Chikermane SG, Thompson C, et al
    Long-Term Risk of Reintervention after Transcatheter Aortic Valve Replacement.
    Am Heart J. 2023 Oct 21:S0002-8703(23)00296-X. doi: 10.1016/j.ahj.2023.
    >> Share

  16. BAINEY KR, Wood DA, Bossard M, Campo G, et al
    Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
    Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023.
    >> Share

    September 2023
  17. CHEEMA HA, Khan AA, Ahmad AH, Khan AA, et al
    Prophylactic corticosteroids for cardiac surgery in children: A systematic review and meta-analysis.
    Am Heart J. 2023 Sep 14:S0002-8703(23)00279-X. doi: 10.1016/j.ahj.2023.
    >> Share

  18. OHUCHI H, Mori A, Kurosaki K, Shiraishi I, et al
    Prevalence and clinical correlates and characteristics of "Super Fontan".
    Am Heart J. 2023;263:93-103.
    >> Share

  19. O'BYRNE ML, Song L, Huang J, Lemley B, et al
    Attributable mortality benefit of digoxin treatment in hypoplastic left heart syndrome after the Norwood operation: An instrumental variable-based analysis using data from the Pediatric Health Information Systems Database.
    Am Heart J. 2023;263:35-45.
    >> Share

    July 2023
  20. PARK S, Rha SW, Choi BG, Kim W, et al
    Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
    Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
    >> Share

    June 2023
  21. SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al
    Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (The IMPACTavi registry): Design and Rationale.
    Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023.
    >> Share

  22. MADSEN CL, Park-Hansen J, Irmukhamedov A, Carranza CL, et al
    The Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial protocol Rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of pre
    Am Heart J. 2023 Jun 9:S0002-8703(23)00147-3. doi: 10.1016/j.ahj.2023.
    >> Share

  23. BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al
    Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023.
    >> Share

  24. SHECHTER A, Koren O, Skaf S, Makar M, et al
    Transcatheter Edge-to-Edge Repair for Chronic Functional Mitral Regurgitation in Patients with Very Severe Left Ventricular Dysfunction.
    Am Heart J. 2023 Jun 3:S0002-8703(23)00138-2. doi: 10.1016/j.ahj.2023.
    >> Share

  25. STAHL A, Havers-Borgersen E, Ostergaard L, Petersen JK, et al
    Hemodialysis and its impact on Patient Characteristics, Microbiology, Cardiac Surgery, and Mortality in Infective Endocarditis.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00135-7. doi: 10.1016/j.ahj.2023.
    >> Share

    May 2023
  26. BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al
    Patient Characteristics and Long-term Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation in a Failed Surgical Prosthesis versus in a Native Valve: A Danish nationwide study.
    Am Heart J. 2023 May 11:S0002-8703(23)00118-7. doi: 10.1016/j.ahj.2023.
    >> Share

  27. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
    Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
    Am Heart J. 2023;259:68-78.
    >> Share

    April 2023
  28. LAURIDSEN MD, Valentin JB, Strange JE, Jacobsen PA, et al
    Mortality in patients with chronic obstructive pulmonary disorder undergoing transcatheter aortic valve replacement: The importance of chronic obstructive pulmonary disease exacerbation.
    Am Heart J. 2023;262:100-109.
    >> Share

  29. COISNE A, Aghezzaf S, Butruille L, Woitrain E, et al
    Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of Aortic Stenosis.
    Am Heart J. 2023 Apr 24:S0002-8703(23)00099-6. doi: 10.1016/j.ahj.2023.
    >> Share

  30. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    >> Share

  31. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    >> Share

  32. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  33. DEMIREL C, Tomii D, Heg D, Okuno T, et al
    Incidental detection of malignancy during pre-procedural workup for transcatheter aortic valve implantation: a longitudinal cohort study.
    Am Heart J. 2023 Apr 1:S0002-8703(23)00072-8. doi: 10.1016/j.ahj.2023.
    >> Share

    March 2023
  34. DESCAMPS R, Amour J, Besnier E, Bougle A, et al
    Perioperative individualized hemodynamic optimization according to baseline mean arterial pressure in cardiac surgery patients: Rationale and design of the OPTIPAM randomized trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00067-4. doi: 10.1016/j.ahj.2023.
    >> Share

  35. RONG LQ, Franco AD, Rahouma M, Dimagli A, et al
    Postoperative pericardial effusion, pericardiotomy and atrial fibrillation: an explanatory analysis of the PALACS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00063-7. doi: 10.1016/j.ahj.2023.
    >> Share

  36. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    >> Share

    February 2023
  37. ALMOND CS, Sleeper LA, Rossano JW, Bock MJ, et al
    The TEAMMATE Trial: Study Design and Rationale Tacrolimus and Everolimus Against TACROLIMUS and MMF in Pediatric Heart Transplantation Using the Major Adverse Transplant Event (MATE) Score.
    Am Heart J. 2023 Feb 22:S0002-8703(23)00038-8. doi: 10.1016/j.ahj.2023.
    >> Share

  38. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    >> Share

  39. CONEN D, Popova E, Wang MK, Chan MTV, et al
    Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00025-X. doi: 10.1016/j.ahj.2023.
    >> Share

    January 2023
  40. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    >> Share

  41. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    >> Share

  42. HAVERS-BORGERSEN E, Butt JH, Strange J, Carranza CL, et al
    Mortality and Rehospitalization after Mitral Valve Surgery as a Function of Age and Key Comorbidities.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00016-9. doi: 10.1016/j.ahj.2023.
    >> Share

    December 2022
  43. CUBEDDU RJ, Murphy SME, Asher CR, Garcia SA, et al
    Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00333-7. doi: 10.1016/j.ahj.2022.
    >> Share

  44. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    >> Share

  45. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    >> Share

  46. GOLDBERG CS, Gaynor JW, Mahle WT, Ravishankar C, et al
    The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptations.
    Am Heart J. 2022;254:216-227.
    >> Share

  47. TEHRANI DM, Kim JS, Hsu JJ, Nsair A, et al
    Early trends in cardiac allograft vasculopathy after implementation of the 2018 donor heart allocation policy in the United States.
    Am Heart J. 2022;254:23-29.
    >> Share

  48. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    >> Share

    November 2022
  49. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    >> Share

  50. NUIS RJ, van Belle E, Teles R, Blackman D, et al
    BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00295-2. doi: 10.1016/j.ahj.2022.
    >> Share

  51. SAVITZ ST, Leong T, Sung SH, Kitzman DW, et al
    Predicting Short-term Outcomes After Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00286.
    >> Share

    October 2022
  52. CHUNG M, Butala NM, Faridi KF, Almarzooq ZI, et al
    Days at Home after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients.
    Am Heart J. 2022 Oct 26. pii: S0002-8703(22)00275.
    >> Share

  53. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    >> Share

  54. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    >> Share

  55. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    >> Share

  56. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    >> Share

    September 2022
  57. MYLONAS KS, Tasoudis PT, Pavlopoulos D, Kanakis M, et al
    Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data.
    Am Heart J. 2022 Sep 14. pii: S0002-8703(22)00186.
    >> Share

  58. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    >> Share

    August 2022
  59. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    >> Share

  60. KIKANO S, Breeyear J, Aka I, Edwards TL, et al
    Association Between Nitric Oxide Synthase 3 Genetic Variant and Acute Kidney Injury Following Pediatric Cardiac Surgery.
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00164.
    >> Share

  61. SALZMANN S, Laferton JAC, Shedden-Mora MC, Horn N, et al
    Pre-surgery optimization of patients' expectations to improve outcome in heart surgery: Study protocol of the randomized controlled multi-center PSY-HEART-II trial.
    Am Heart J. 2022 Aug 5. pii: S0002-8703(22)00161.
    >> Share

    June 2022
  62. HOLLANDER SA, Barkoff L, Giacone H, Adamson GT, et al
    Risk Factors and Outcomes of Sudden Cardiac Arrest in Pediatric Heart Transplant Recipients.
    Am Heart J. 2022 Jun 12. pii: S0002-8703(22)00127.
    >> Share

  63. TOMII D, Pilgrim T, Heg D, Reineke D, et al
    Reply: Correlation of aortic root dimensions in patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2022;248:166-168.
    >> Share

  64. GUPTA K, Lee JC
    Assessment of sinus of valsalva dimensions before TAVI: An independent predictor of worse outcomes?
    Am Heart J. 2022;248:165.
    >> Share

    May 2022
  65. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    >> Share

  66. PAHUJA M, Case BC, Molina EJ, Waksman R, et al
    Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart - portable extracorporeal heart perfusion and monitoring system.
    Am Heart J. 2022;247:90-99.
    >> Share

    April 2022
  67. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    >> Share

  68. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    >> Share

    March 2022
  69. VERMA S, Rathwell S, Fremes S, Zheng Y, et al
    Associated Factors and Clinical Outcomes in Mechanical Circulatory Support use in Patients Undergoing High Risk On-Pump Cardiac Surgery: Insights from the LEVO-CTS trial.
    Am Heart J. 2022 Mar 6. pii: S0002-8703(22)00046.
    >> Share

    February 2022
  70. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    >> Share

  71. LINDER M, Higgen FL, Voigtlander L, Weimann J, et al
    Stroke events after transcatheter aortic valve implantation: Temporal relationships and affected brain regions.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00030.
    >> Share

    January 2022
  72. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    >> Share

  73. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    >> Share

  74. HERRMANN HC, Abdel-Wahab M, Attizzani GF, Batchelor W, et al
    Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial).
    Am Heart J. 2022;243:92-102.
    >> Share

  75. BUTALA NM, Song Y, Shen C, Cohen DJ, et al
    Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial.
    Am Heart J. 2022;243:77-86.
    >> Share

    December 2021
  76. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    >> Share

    November 2021
  77. I D, Okuno T, Heg D, Grani C, et al
    Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
    Am Heart J. 2021 Nov 14. pii: S0002-8703(21)00447.
    >> Share

  78. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    >> Share

  79. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    >> Share

  80. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    >> Share

    October 2021
  81. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    >> Share

    September 2021
  82. STRANGE JE, Sindet-Pedersen C, Gislason GH, Torp-Pedersen C, et al
    Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00239.
    >> Share

  83. CLARK KA, Chouairi F, Kay B, Reinhardt SW, et al
    Trends in Transcatheter and Surgical Aortic Valve Replacement in the United States, 2008-2018.
    Am Heart J. 2021 Sep 24. pii: S0002-8703(21)00232.
    >> Share

    June 2021
  84. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016